CareMax, Inc. Schedules 2021 Fourth Quarter and Full Year Financial Results Conference Call

Rhea-AI Summary

CareMax, Inc. (NASDAQ: CMAX; CMAXW) will release its financial results for Q4 and full year 2021 on March 8, 2022, before market opening. A conference call will be held at 8:30 am ET the same day for management to discuss results and business activities. CareMax provides value-based care and chronic disease management to seniors through its technology-enabled platform. Interested participants can join the call via domestic and international numbers, and a live webcast will be available on their investor relations website.

Positive

• CareMax operates a technology-enabled care platform that addresses the needs of seniors.
• The company is set to report its financial results, indicating ongoing business activity.

Negative

• None.

MIAMI--(BUSINESS WIRE)-- CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading technology-enabled provider of value-based care to seniors, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2021 before the opening of the financial markets on Tuesday, March 8, 2022. Management will host a conference call that morning at 8:30 am ET to discuss the results and business activities.

Interested parties may participate in the call by dialing:

• (877) 407-9753 (Domestic) or
• (201) 493-6739 (International)

A live webcast and replay of the event will be available on the “Events & Presentations” section of CareMax’s investor relations website at ir.caremax.com.

About CareMax

CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors. CareMax operates medical centers that offer a comprehensive suite of healthcare and social services, and a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians across the United States. Learn more at www.caremax.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements include statements regarding our future growth and strategy. Words such as "anticipate," "believe," "budget," "contemplate," "continue," "could," "envision," "estimate," "expect," "guidance," "indicate," "intend," "may," "might," "plan," "possibly," "potential," "predict," "probably," "pro-forma," "project," "seek," "should," "target," or "will," or the negative or other variations thereof, and similar words or phrases or comparable terminology, are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those indicated in forward-looking statements include, among others, the availability of sites for medical facilities and the costs of opening such medical facilities; changes in market or industry conditions, regulatory environment, competitive conditions, and receptivity to the Company's services; the Company's ability to continue its growth, including in new markets; changes in laws and regulations applicable to the Company's business, in particular with respect to Medicare Advantage or Medicaid; the Company's ability to maintain its relationships with health plans and other key payers; the impact of COVID-19 or another pandemic, epidemic or outbreak of infectious disease on the Company's business and results of operation; and the Company's ability to recruit and retain qualified team members and independent physicians. For a detailed discussion of the risk factors that could affect the Company's actual results, please refer to the risk factors identified in the Company's reports filed with the SEC. All information provided in this press release is as of the date hereof, and the Company undertakes no duty to update or revise this information unless required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220224005903/en/

CareMax, Inc.

Samantha Swerdlin, VP Investor Relations

(847) 924-8980

samantha.swerdlin@caremax.com

The Equity Group Inc.

Devin Sullivan, SVP

(212) 836-9608

dsullivan@equityny.com

Source: CareMax, Inc.

FAQ

When will CareMax release its financial results for Q4 2021?

CareMax will release its financial results on March 8, 2022, before market opening.

What time is the CareMax conference call on March 8, 2022?

The conference call will be held at 8:30 am ET on March 8, 2022.

How can I participate in CareMax's earnings call?

Participants can join by calling (877) 407-9753 for domestic or (201) 493-6739 for international.

What is the focus of CareMax's business?

CareMax focuses on providing value-based care and chronic disease management to seniors.

Where can I find the webcast of the CareMax earnings call?

The webcast will be available on CareMax's investor relations website in the 'Events & Presentations' section.